华东医药：公司创新药研发中心正在推进80余项创新药管线研发，绝大部分为1类创新药

Group 1 - The company has announced that it is advancing over 80 innovative drug pipelines, which include both preclinical and clinical research projects, with the majority being Class 1 innovative drugs [2] - The inquiry from investors on the interactive platform pertains to whether the 80 innovative drugs correspond to 80 new molecular entities [2] - The company confirmed that its innovative drug research center is actively working on these projects [2]